Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.
| Takeda Pharmaceuticals U.S.A., Inc. |
| Mylan Pharmaceuticals Inc. |
| Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc. |
| Par Pharmaceutical Inc. |
| 1:2019cv02216 |
| December 2, 2019 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent |
| 35 U.S.C. § 271 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 23, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 122
REDACTED VERSION of #87 Declaration, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D)(DiGiovanni, Francis) Modified on 1/30/2020 (nms).
|
|
Filing 121
ORDER of USCA as to #118 Notice of Appeal (Federal Circuit), filed by Takeda Pharmaceuticals U.S.A., Inc.. Decision of USCA on Motion: Mylan is directed to respond to the motion for an injunction pending appeal no later than seven days from the date of filing of this order. Any reply in support of the motion is due no later than three days thereafter. Takeda's request for an interim injunction is granted to the extent that the district court's order that Mylan "maintain the status quo" shall remain in effect pending the court's consideration of Takeda's request for an injunction pending appeal. (nms)
|
|
Filing 120
NOTICE of Withdrawal of Motion to Seal by Mylan Pharmaceuticals Inc. re #104 MOTION to File Under Seal and Response to Motion to File Under Seal, #105 Exhibit to a Document (Dorsney, Kenneth)
|
|
Filing 119
TRANSCRIPT REQUEST by Takeda Pharmaceuticals U.S.A., Inc. for proceedings held on January 21, 2020 before Judge Richard G. Andrews. (Rahmeier, Thatcher)
|
|
Filing 118
Amended NOTICE OF APPEAL to the Federal Circuit of #114 Memorandum Order. Appeal filed by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) Modified on 1/28/2020 (nms).
|
|
Filing 117
NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re #115 Notice of Appeal (Federal Circuit), filed by Takeda Pharmaceuticals U.S.A., Inc.. USCA Case Number 2020-1407. (nms)
|
|
Filing 116
REDACTED VERSION of #94 Declaration, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: #1 Exhibit A)(DiGiovanni, Francis) Modified on 1/28/2020 (nms).
|
|
REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI #87 . (nms)
|
|
CORRECTING ENTRY: The pdf for D.I. #114 has been replaced with a corrected version. The first word in the last paragraph on Page 3 has been corrected. The NEF for the filing has been regenerated. (nms)
|
|
Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re #118 Notice of Appeal (Federal Circuit). (kmd)
|
|
REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI #94 . (nms)
|
|
APPEAL - Credit Card Payment of $505.00 received re #118 Notice of Appeal (Federal Circuit) filed by Takeda Pharmaceuticals U.S.A., Inc.. ( Filing fee $505, receipt number 0311-2837667.) (DiGiovanni, Francis)
|
|
Filing 115
NOTICE OF APPEAL to the Federal Circuit of #114 Memorandum Order. Appeal, filed by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) Modified on 1/28/2020 (nms).
|
|
Filing 114
MEMORANDUM ORDER: The Motion for Preliminary Injunction (D.I. #12 ) is DENIED. For the same reasons that I do not grant the preliminary injunction, I do not grant any stay pending appeal, except that, in order to give Plaintiff an opportunity to seek immediate relief in the Court of Appeals, if it so chooses, Defendant is ORDERED to maintain the status quo until end of the day January 31, 2020. Signed by Judge Richard G. Andrews on 1/27/2020. (nms) (Main Document 114 replaced on 1/28/2020) (nms).
|
|
Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re #115 Notice of Appeal (Federal Circuit). (nmg)
|
|
APPEAL - Credit Card Payment of $505.00 received re #115 Notice of Appeal (Federal Circuit) filed by Takeda Pharmaceuticals U.S.A., Inc.. ( Filing fee $505, receipt number 0311-2835944.) (DiGiovanni, Francis)
|
|
Filing 113
RESPONSE to #111 MOTION for Leave to Participate as an Amicus Curiae, filed by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 1/24/2020 (nms).
|
|
Set Answering Brief Deadline re #111 MOTION for Leave to Participate as an Amicus Curiae. Answering Brief/Response due date per Local Rules is 2/6/2020. (nms)
|
|
Filing 112
Letter to The Honorable Richard G. Andrews, from Dominick T. Gattuso, Esq., regarding Motion for Leave to Participate as an Amicus Curiae (D.I. #111 ). (Gattuso, Dominick) Modified on 1/24/2020 (nms).
|
|
Filing 111
MOTION for Leave to Participate as an Amicus Curiae - filed by Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals International Limited. (Gattuso, Dominick) Modified on 1/24/2020 (nms).
|
|
Filing 110
REDACTED VERSION of #81 Sealed Exhibits, by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 1/23/2020 (nms).
|
|
Filing 109
REDACTED VERSION of #97 Memorandum in Opposition, by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 1/23/2020 (nms).
|
|
Filing 108
REDACTED VERSION of #73 Sealed Exhibits, by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 1/23/2020 (nms).
|
|
Filing 107
REDACTED VERSION of #76 Opening Brief in Support, by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 1/23/2020 (nms).
|
|
Filing 106
REDACTED VERSION of #64 Declaration of Thatcher A. Rahmeier, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(DiGiovanni, Francis) Modified on 1/23/2020 (nms).
|
|
CORRECTING ENTRY: The pdf for D.I. 105 has been replaced with an amended version per counsel's request. The organization of the pages has been corrected. (nms)
|
|
Filing 105
[SEALED] EXHIBITS re #104 MOTION to File Under Seal and Response to Motion to File Under Seal, by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 1/23/2020 (nms). (Main Document 105 replaced on 1/23/2020) (nms).
|
|
Filing 104
MOTION to File Under Seal and Response to Motion to File Under Seal - filed by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 1/23/2020 (nms).
|
|
Filing 103
REDACTED VERSION of #13 Opening Brief in Support, by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) Modified on 1/22/2020 (nms).
|
|
Filing 102
[SEALED] DECLARATION of Mark J. Buonaiuto, Esq. re #101 Sealed Reply Brief, by Takeda Pharmaceuticals U.S.A., Inc.. (nms)
|
|
Filing 101
[SEALED] REPLY BRIEF re #12 MOTION for Preliminary Injunction, filed by Takeda Pharmaceuticals U.S.A., Inc.. (nms)
|
|
Filing 100
ORDER Granting #84 Motion to File Under Seal Reply Memorandum and Declaration in Support of Motion for a Preliminary Injunction. Signed by Judge Richard G. Andrews on 1/22/2020. (nms)
|
|
REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI #73 . (nms)
|
|
REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI #64 . (nms)
|
|
Filing 99
ORDER Granting #93 MOTION to File Under Seal Takeda's Opening Brief in Support of Takeda's Motion for Preliminary Injunction. Signed by Judge Richard G. Andrews on 1/21/2020. (nms)
|
|
Filing 98
ORAL ORDER: After oral argument and for the reasons stated in open court, Pars motion to intervene (D.I. #26 ) is DENIED. Ordered by Judge Richard G. Andrews on 1/21/2020. (nms)
|
|
Filing 97
[SEALED] MEMORANDUM of Law in Response to #47 Brief in Support of Takeda's Motion for Preliminary Injunction, filed by Mylan Pharmaceuticals Inc.. (nms)
|
|
Filing 96
ORDER: The Motion to Seal Certain Portions of Mylan's Memorandum of Law in Response to Par's Brief in Support of Takeda's Motion for Preliminary Injunction (D.I. #77 ) is GRANTED except as noted (see Order for further details). Signed by Judge Richard G. Andrews on 1/21/2020. (nms)
|
|
Minute Entry for proceedings held before Judge Richard G. Andrews - Oral Argument held on 1/21/2020 re #26 MOTION to Intervene and #12 MOTION for Preliminary Injunction. Local counsel present for plaintiff: F. DiGiovanni, T. Rahmeier. Counsel present for defendant: M. Sommer, J. Margolis, and S. Bassin. Local counsel present for proposed Intervenor: K. Keller. (Court Reporter Stacy Ingram.) (crb)
|
|
SO ORDERED, re #95 STIPULATION TO EXTEND TIME To File Answering Brief to Motion to Dismiss (D.I. #71 ) to the later of (a) January 31, 2020; or (b) Five (5) Business Days after this Court Rules on Takeda's Motion for Preliminary. Signed by Judge Richard G. Andrews on 1/21/2020. (nms)
|
|
Filing 95
STIPULATION TO EXTEND TIME To File Answering Brief to Mylan Pharmaceuticals, Inc.'s Motion to Dismiss (D.I. 71) to the later of (a) January 31, 2020; or (b) Five (5) Business Days after this Court Rules on Takeda's Motion for Preliminary Injunction (D.I. 72) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis)
|
|
Filing 94
[SEALED] DECLARATION re #93 Motion to File Under Seal Takeda's Opening Brief in Support of Takeda's Motion for Preliminary Injunction, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: #1 Exhibit A)(DiGiovanni, Francis) Modified on 1/21/2020 (nms).
|
|
Filing 93
MOTION to File Under Seal Takeda's Opening Brief in Support of Takeda's Motion for Preliminary Injunction - filed by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) Modified on 1/21/2020 (nms).
|
|
CORRECTING ENTRY: D.I. 85 has been removed from the docket as it was duplicative of the filing at D.I. #87 . (nms)
|
|
CORRECTING ENTRY: The main pdf for D.I. 87 has been replaced per the Court's request to reflect that the filing is being made under seal. (nms)
|
|
CORRECTING ENTRY: The pdf for D.I. #24 has been replaced with an amended version. A correction has been made to page 3. (nms)
|
|
Filing 90
AFFIDAVIT of Christie L. Larochelle re #88 Redacted Document filed by Par Pharmaceutical Inc.. (Keller, Karen)
|
|
Filing 89
DECLARATION of Porter F. Fleming re #12 Motion for Preliminary Injunction, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: #1 Exhibit 20)(DiGiovanni, Francis) Modified on 1/17/2020 (nms).
|
|
Filing 88
REDACTED VERSION of #86 Reply Brief, by Par Pharmaceutical Inc.. (Keller, Karen) Modified on 1/17/2020 (nms).
|
|
Filing 87
[SEALED] DECLARATION re #84 Motion to File Under Seal, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D)(DiGiovanni, Francis) Modified on 1/17/2020 (nms). (Main Document 87 replaced on 1/17/2020) (nms).
|
|
Filing 86
[SEALED] REPLY BRIEF re #12 MOTION for Preliminary Injunction filed by Par Pharmaceutical Inc.. (Keller, Karen)
|
|
Filing 84
Motion to File Under Seal Reply Memorandum and Declaration in Support of Motion for a Preliminary Injunction - filed by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) Modified on 1/17/2020 (nms).
|
|
Filing 83
ORAL ORDER: The hearing scheduled for 1/21/2020, will now also address the Motion to Intervene (D.I. #26 ). Ordered by Judge Richard G. Andrews on 1/16/2020. (nms)
|
|
Filing 82
REPLY BRIEF re #26 MOTION to Intervene filed by Par Pharmaceutical Inc.. (Keller, Karen)
|
|
Filing 81
[SEALED] EXHIBITS re #77 MOTION to Seal Certain Portions of Mylan's Memorandum of Law in Response to Par's Brief in Support of Takeda's Motion for Preliminary Injunction, by Mylan Pharmaceuticals Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Certificate of Service)(Dorsney, Kenneth) Modified on 1/14/2020 (nms).
|
|
Filing 80
DECLARATION by Sheryl S. Bassin in support of Response to Par's Brief in Support of Takeda's Motion for Preliminary Injunction, by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 1/14/2020 (nms).
|
|
Filing 77
MOTION to Seal Certain Portions of Mylan's Memorandum of Law in Response to Par's Brief in Support of Takeda's Motion for Preliminary Injunction - filed by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 1/14/2020 (nms).
|
|
Filing 76
[SEALED] OPENING BRIEF in Support re #71 MOTION to Dismiss, filed by Mylan Pharmaceuticals Inc.. (nms)
|
|
Filing 75
ORDER Granting #72 Unopposed MOTION to File Under Seal. Signed by Judge Richard G. Andrews on 1/13/2020. (nms)
|
|
CORRECTING ENTRY: The exhibits filed at D.I. 78, 79, and 81 have been removed from the docket as they were to be filed together at a single docket item transaction (*see Correcting Entry filed on 1/2/2020). (nms)
|
|
CORRECTING ENTRY: The letter filed at D.I. 83 has been removed from the docket as it was captioned for a different case. (nms)
|
|
Filing 74
REQUEST for Oral Argument by Mylan Pharmaceuticals Inc. re #71 MOTION to Dismiss for Failure to State a Claim . (Dorsney, Kenneth)
|
|
Filing 73
[SEALED] EXHIBITS to #72 Unopposed MOTION to File Under Seal, by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 1/13/2020 (nms).
|
|
Filing 72
Unopposed MOTION to File Under Seal - filed by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 1/13/2020 (nms).
|
|
Filing 71
MOTION to Dismiss - filed by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 1/13/2020 (nms).
|
|
Filing 70
REDACTED VERSION of #40 Exhibits, by Mylan Pharmaceuticals Inc.. (Attachments: #1 Declaration)(Dorsney, Kenneth) Modified on 1/9/2020 (nms).
|
|
CORRECTING ENTRY: The redacted filings at D.I. 70 and D.I. 71 have been removed from the docket. These filings were made in relation to D.I. 40. D.I. 40 contained two exhibits that were filed together, therefore the redaction should maintain that same continuity. (nms)
|
|
Filing 69
REDACTED VERSION of #68 Answering Brief in Opposition by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis)
|
|
Filing 68
[SEALED] ANSWERING BRIEF to #26 MOTION to Intervene, filed by Takeda Pharmaceuticals U.S.A., Inc..Reply Brief due date per Local Rules is 1/15/2020. (nms)
|
|
Filing 67
ORDER Granting #63 MOTION to File Under Seal Certain Portions of Answering Brief to Motion to Intervene. Signed by Judge Richard G. Andrews on 1/8/2020. (nms)
|
|
Filing 66
CERTIFICATE OF SERVICE of the Declaration of Domenico Ciarico and the Declaration of Walter H.A. Vandaele, Ph.D. (D.I. #49 ; D.I. #50 ), by Par Pharmaceutical Inc.. (Keller, Karen) Modified on 1/8/2020 (nms).
|
|
CORRECTING ENTRY: The certificate of service filed at D.I. 58 has been removed from the docket. The filing was not appropriately formatted. Counsel shall refile the certificate which shall include a case caption. (nms)
|
|
Filing 92
[SEALED] DECLARATION of Keith Meckstroth re #91 Sealed Answering Brief in Opposition, by Mylan Pharmaceuticals Inc.. (nms) Modified on 1/17/2020 (nms).
|
|
Filing 91
SEALED ANSWERING BRIEF in Opposition re #12 MOTION for Preliminary Injunction, filed by Mylan Pharmaceuticals Inc.. (nms) Modified on 1/17/2020 (nms).
|
|
Filing 65
DECLARATION of Mark J. Buonaiuto, Esq. re #26 Motion to Intervene, by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) Modified on 1/8/2020 (nms).
|
|
Filing 64
[SEALED] DECLARATION of Thatcher A. Rahmeier re #63 Motion to File Under Seal, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(DiGiovanni, Francis) Modified on 1/8/2020 (nms).
|
|
Filing 63
MOTION to File Under Seal Certain Portions of Answering Brief to Motion to Intervene - filed by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) Modified on 1/8/2020 (nms).
|
|
Filing 62
RESPONSE to #26 MOTION to Intervene, filed by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 1/8/2020 (nms).
|
|
Filing 61
ORDER re #55 Stipulation Regarding Supplemental Briefing (see Order for further details). Signed by Judge Richard G. Andrews on 1/7/2020. (nms)
|
|
Filing 60
ORDER RE SEALING: The motion to seal (D.I. #33 ) is GRANTED IN PART AND DENIED IN PART. Mylan should promptly make the appropriate redactions to Exhibits A and B, and file them. Signed by Judge Richard G. Andrews on 1/7/2020. (nms) Modified on 1/17/2020 (nms).
|
|
Filing 59
ORAL ORDER: A hearing on the Motion for Preliminary Injunction (D.I. #12 ) is now scheduled for 1/21/2020, at 10:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 1/7/2020. (nms)
|
|
CORRECTING ENTRY: The docket text for D.I. #47 has been corrected to show the filing is an Answering Brief in support and not an Opening Brief in support. The incorrect filing event code was used. The language regarding the answering brief due date has been removed. (nms)
|
|
Filing 57
Letter to The Honorable Richard G. Andrews, from Francis DiGiovanni, regarding response to #55 Stipulation and #56 Letter. (DiGiovanni, Francis) Modified on 1/7/2020 (nms).
|
|
Filing 56
Letter to The Honorable Richard G. Andrews from Karen E. Keller regarding Par's Motion to Intervene. (Keller, Karen)
|
|
Filing 55
STIPULATION and Proposed Order Regarding Supplemental Briefing In Support of Takeda's Motion For Preliminary Injunction, by Par Pharmaceutical Inc.. (Keller, Karen) Modified on 1/7/2020 (nms).
|
|
Filing 54
REDACTED VERSION of #49 Declaration of Domenico Ciarico, by Par Pharmaceutical Inc.. (Keller, Karen) Modified on 1/7/2020 (nms).
|
|
Filing 53
REDACTED VERSION of #50 Declaration of Walter H. A. Vandaele, Ph.D., by Par Pharmaceutical Inc.. (Keller, Karen) Modified on 1/7/2020 (nms).
|
|
Filing 52
REDACTED VERSION of #47 MEMORANDUM in Support, by Par Pharmaceutical Inc.. (Keller, Karen) Modified on 1/7/2020 (nms).
|
|
Filing 51
AFFIDAVIT of Christie L. Larochelle regarding proposed redacted filings, filed by Par Pharmaceutical Inc.. (Keller, Karen) Modified on 1/7/2020 (nms).
|
|
Filing 50
[SEALED] DECLARATION of Walter H. A. Vandaele, Ph.D. re #47 MEMORANDUM in Support, by Par Pharmaceutical Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8a, #9 Exhibit 8b, #10 Exhibit 8c, #11 Exhibit 8d, #12 Exhibit 8e, #13 Exhibit 9, #14 Appendix)(Keller, Karen) Modified on 1/7/2020 (nms).
|
|
Filing 49
[SEALED] DECLARATION of Domenico Ciarico re #47 MEMORANDUM in Support, by Par Pharmaceutical Inc.. (Attachments: #1 Exhibit A)(Keller, Karen) Modified on 1/7/2020 (nms).
|
|
Filing 48
DECLARATION of Samuel E.C. Sherry, by Par Pharmaceutical Inc.. (Attachments: #1 Exhibit 1)(Keller, Karen) Modified on 1/7/2020 (nms).
|
|
Filing 47
[SEALED] Brief in Support re #12 MOTION for Preliminary Injunction, filed by Par Pharmaceutical Inc.. (Keller, Karen) Modified on 1/7/2020 (nms). Modified on 1/21/2020 (nms).
|
|
Filing 46
[SEALED] AFFIDAVIT of Vinny Lee re #33 MOTION to File Under Seal, filed by Mylan Pharmaceuticals Inc.. (nms)
|
|
CORRECTING ENTRY: The sealed affidavit of Vinny Lee filed at D.I. 40 has been removed from that entry as it is not one of the documents being requested to be filed under seal, but is in further support of the motion to seal. The affidavit has been re-docketed at D.I. #46 . (nms)
|
|
SO ORDERED, re #45 STIPULATION and Proposed Order for Extension of Due Date (*Reset Briefing Schedule: re #26 MOTION to Intervene. Answering Brief due 1/7/2020). Signed by Judge Richard G. Andrews on 1/3/2020. (nms)
|
|
Filing 45
STIPULATION and Proposed Order for Extension of Due Date - filed by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) Modified on 1/3/2020 (nms).
|
|
Filing 44
SO ORDERED re #38 STIPULATION and Order for Extension of Time (*Reset Briefing Schedule: re #12 MOTION for Preliminary Injunction. Reply Brief due 1/10/2020) (*Reset Answer Deadlines: Mylan Pharmaceuticals Inc. answer due 1/10/2020). Signed by Judge Richard G. Andrews on 1/2/2020. (nms)
|
|
CORRECTING ENTRY: D.I. 41 and D.I. 42 have been removed from the docket. The sealed exhibits filed at that entry have been added to the filing at D.I. 40. All sealed exhibits should have been filed together. (nms)
|
|
SO ORDERED, re #28 STIPULATION TO EXTEND TIME to file answering brief to December 23, 2019. Signed by Judge Richard G. Andrews on 1/2/2020. (nms)
|
|
Filing 43
EXHIBIT re #33 MOTION to File Under Seal, by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 1/2/2020 (nms).
|
|
Filing 40
[SEALED] EXHIBITS re #33 MOTION to File Under Seal, by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 1/2/2020 (nms). (Additional attachment(s) added on 1/2/2020: #1 Declaration of Keith Meckstroth) (nms). Modified on 1/3/2020 (nms).
|
|
CORRECTING ENTRY: D.I. 34, 35, 36, and 37 have been removed from the docket. These filing should have been filed at the same entry under the code of Sealed Exhibits to the Motion at D.I. #33 . Counsel shall refile accordingly. (nms)
|
|
CORRECTING ENTRY: The pdf for D.I. 24 has been replaced with a corrected version. A typo on page one has been corrected. The NEF for the filing has been regenerated. (nms)
|
|
Filing 39
AFFIDAVIT of Christie L. Larochelle re #32 Redacted Document, #31 Redacted Document filed by Par Pharmaceutical Inc.. (Keller, Karen)
|
|
Pro Hac Vice Attorney Jessica L. Margolis for Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
|
|
Pro Hac Vice Attorney Sheryl S. Bassin for Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
|
|
Filing 38
STIPULATION TO EXTEND TIME Various Deadlines to - filed by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis)
|
|
Filing 33
MOTION to File Under Seal - filed by Mylan Pharmaceuticals Inc.. (Attachments: #1 Text of Proposed Order)(Dorsney, Kenneth) Modified on 12/27/2019 (nms).
|
|
Filing 32
REDACTED VERSION of #29 Declaration by Par Pharmaceutical Inc.. (Keller, Karen)
|
|
Filing 31
REDACTED VERSION of #27 MEMORANDUM in Support, by Par Pharmaceutical Inc.. (Keller, Karen)
|
|
Filing 30
Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Endo International, PLC for Par Pharmaceutical Inc. filed by Par Pharmaceutical Inc.. (Keller, Karen)
|
|
Filing 29
[SEALED] DECLARATION re #26 MOTION to Intervene by Par Pharmaceutical Inc.. (Keller, Karen)
|
|
Filing 28
STIPULATION TO EXTEND TIME file answering brief to motion for preliminary injunction to December 23, 2019 - filed by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth)
|
|
Filing 27
[SEALED] MEMORANDUM in Support re #26 MOTION to Intervene, filed by Par Pharmaceutical Inc..Answering Brief/Response due date per Local Rules is 1/3/2020. (Attachments: #1 Tab 1)(Keller, Karen) Modified on 12/27/2019 (nms).
|
|
Filing 26
MOTION to Intervene - filed by Par Pharmaceutical Inc.. (Attachments: #1 Text of Proposed Order)(Keller, Karen)
|
|
Filing 25
REDACTED VERSION of #2 Complaint, by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) Modified on 12/20/2019 (nms).
|
|
Filing 24
MEMORANDUM ORDER: The Motion for Confidential Treatment (D.I. #1 ) is GRANTED in part and DENIED in part (see Memorandum Order for details). Signed by Judge Richard G. Andrews on 12/19/2019. (nms) (Main Document 24 replaced on 12/27/2019) (nms). (Main Document 24 replaced on 1/17/2020) (nms).
|
|
Pro Hac Vice Attorney Shyamkrishna Palaiyanur for Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
|
|
Filing 23
REDACTED VERSION of #16 Declaration by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis)
|
|
Filing 22
REDACTED VERSION of #15 Declaration,, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19)(DiGiovanni, Francis)
|
|
Filing 21
REDACTED VERSION of #13 Opening Brief in Support, by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) Modified on 12/12/2019 (nms).
|
|
Filing 20
REDACTED VERSION of #2 Complaint, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K, #12 Exhibit L, #13 Exhibit M, #14 Exhibit N, #15 Exhibit O, #16 Exhibit P, #17 Exhibit Q, #18 Exhibit R, #19 Exhibit S, #20 Exhibit T, #21 Exhibit U, #22 Exhibit V, #23 Exhibit W, #24 Exhibit X, #25 Exhibit Y, #26 Exhibit Z)(DiGiovanni, Francis) Modified on 12/12/2019 (nms).
|
|
SO ORDERED, re #19 STIPULATION and Proposed Order Regarding Filing of Redacted Documents. Signed by Judge Richard G. Andrews on 12/10/2019. (nms)
|
|
CORRECTING ENTRY: The main pdf for D.I. 2 has been replaced with a corrected version per counsel's request. Typographical errors have been corrected. (nms)
|
|
Pro Hac Vice Attorney David S. Steuer for Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
|
|
Filing 19
STIPULATION and Proposed Order Regarding Filing of Redacted Documents - filed by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) Modified on 12/10/2019 (nms).
|
|
Pro Hac Vice Attorney Nicole W. Stafford for Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
|
|
SO ORDERED, re #18 MOTION for Pro Hac Vice Appearance of Attorney Paul Gross, filed by Mylan Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 12/9/2019. (nms)
|
|
Filing 18
MOTION for Pro Hac Vice Appearance of Attorney Paul Gross - filed by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth)
|
|
Filing 17
NOTICE OF SERVICE re #16 Declaration, #13 Opening Brief in Support, #12 MOTION for Preliminary Injunction, and #15 Declaration, filed by Takeda Pharmaceuticals U.S.A., Inc..(DiGiovanni, Francis) Modified on 12/9/2019 (nms).
|
|
SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney Sheryl Shapiro Bassin, Attorney Jessica L. Margolis and Attorney Stu A. Williams, filed by Mylan Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 12/6/2019. (nms)
|
|
Pro Hac Vice Attorney Edgar H. Haug for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
|
|
Pro Hac Vice Attorney Nicholas F. Giove and Porter F. Fleming for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
|
|
Filing 16
[SEALED] DECLARATION of Mark J. Buonaiuto re #12 MOTION for Preliminary Injunction, by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) Modified on 12/6/2019 (nms).
|
|
Filing 15
[SEALED] DECLARATION re #12 MOTION for Preliminary Injunction, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19)(DiGiovanni, Francis) Modified on 12/6/2019 (nms).
|
|
Filing 14
MOTION for Pro Hac Vice Appearance of Attorney Sheryl Shapiro Bassin, Attorney Jessica L. Margolis and Attorney Stu A. Williams - filed by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth)
|
|
Filing 13
[SEALED] OPENING BRIEF in Support re #12 MOTION for Preliminary Injunction filed by Takeda Pharmaceuticals U.S.A., Inc..Answering Brief/Response due date per Local Rules is 12/19/2019. (DiGiovanni, Francis)
|
|
Filing 12
MOTION for Preliminary Injunction - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: #1 Text of Proposed Order)(DiGiovanni, Francis)
|
|
Filing 11
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc. for Mylan Pharmaceuticals Inc. filed by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth)
|
|
Filing 10
Non-Opposition re #1 MOTION to Seal, by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 12/5/2019 (nms).
|
|
Filing 9
MOTION for Pro Hac Vice Appearance of Attorney Shyam Palaiyanur, Attorney Michael S. Sommer, Attorney Nicole W. Stafford and Attorney David S. Steuer - filed by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth)
|
|
Filing 8
SO ORDERED Granting #7 Stipulation and Order and Schedule for Preliminary Injunction Proceedings. Signed by Judge Richard G. Andrews on 12/5/2019. (nms)
|
|
Filing 7
STIPULATION and Proposed Order and Schedule for Preliminary Injunction Proceedings, by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) Modified on 12/5/2019 (nms).
|
|
SO ORDERED, re #9 MOTION for Pro Hac Vice Appearance of Attorney Shyam Palaiyanur, Attorney Michael S. Sommer, Attorney Nicole W. Stafford and Attorney David S. Steuer, filed by Mylan Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 12/5/2019. (nms)
|
|
SO ORDERED, re #6 MOTION for Pro Hac Vice Appearance of Attorney Edgar H. Haug, Porter F. Fleming and Nicholas F. Giove, filed by Takeda Pharmaceuticals U.S.A., Inc.. Signed by Judge Richard G. Andrews on 12/4/2019. (nms)
|
|
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
|
|
Filing 6
MOTION for Pro Hac Vice Appearance of Attorney Edgar H. Haug, Porter F. Fleming and Nicholas F. Giove - filed by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis)
|
|
Filing 5
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc)
|
|
Summons Issued with Magistrate Consent Notice attached as to Mylan Pharmaceuticals Inc. on 12/2/2019. (rwc)
|
|
Remark : Exit copies to RGA chambers upon receipt of bound copy of DI# 2 and replacement Exhibits V & W. (rwc)
|
|
CORRECTING ENTRY: Replaced Exhibits V & W (DI 2) with new non-corrupted pdf files. (rwc)
|
|
Filing 4
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Limited, Corporate Parent Takeda Pharmaceuticals International AG for Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceuticals U.S.A., Inc. (rwc)
|
|
Filing 3
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) - (SEE ATTACHED LIST). (rwc)
|
|
Filing 2
[SEALED] COMPLAINT - filed with Jury Demand against Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 032729.) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K, #12 Exhibit L, #13 Exhibit M, #14 Exhibit N, #15 Exhibit O, #16 Exhibit P, #17 Exhibit Q, #18 Exhibit R, #19 Exhibit S, #20 Exhibit T, #21 Exhibit U, #22 Exhibit V, #23 Exhibit W, #24 Exhibit X, #25 Exhibit Y, #26 Exhibit Z)(rwc) (Attachment 22 replaced on 12/3/2019) (rwc). (Attachment 23 replaced on 12/3/2019) (rwc). (Main Document 2 replaced on 12/10/2019) (nms).
|
|
Filing 1
Expedited Motion For Confidential Treatment of Certain Filings - filed by Takeda Pharmaceuticals U.S.A., Inc. - filed by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: #1 Civil Cover Sheet)(rwc) Modified on 12/4/2019 (nms).
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
